It’s no secret that big pharma has been getting leaner, with companies buying and selling businesses to play to their strengths. Novo Nordisk‘s plans to spin off its IT solutions business, NNIT, fits that pattern too. Although it announced intentions to review this option earlier this year, a few different press organizations, including Reuters, have […]
Aramark has opened a technology and innovation center in Charlotte, North Carolina to do a better job of working with hospitals to fix hospital’s imaging and equipment, according to a company statement. Victor Crawford, COO of Aramark’s Healthcare Sector, said the center would include supply chain management, research and development to improve the way it […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Walgreens, like some other national drugstore chains, wants to be seen as part of a healthcare network first rather than a convenient general store with prescription meds. CVS Health made the first rebranding move. Although its collaboration with Theranos marks Walgreens’ most high-profile move in that direction, there are other things the national chain has […]
Employers interested in using employer plans to pare down unnecessary healthcare costs could draw some encouragement from a report highlighting what a handful of companies achieved by rolling out these plans. The report Driving Innovation in the Health Care Marketplace by Business Roundtable seeks to show what happens when employers can make use of greater […]
Johnson & Johnson and Sanofi are using IBM Watson’s computer brain/big data cruncher to support research and development. It will be used to identify new applications for drugs that have already been developed and to leaf through scientific papers that detail clinical trial outcomes, according to a statement from IBM. The partnerships follow a new […]
(Reuters) Express Scripts Holding Co, the largest U.S. pharmacy benefit manager, on Friday said it will remove 25 products from its 2015 list of preferred drugs, including anemia treatments Epogen and Aranesp, both sold by Amgen Inc. The company will continue to include Procrit, a similar anemia drug sold by Johnson & Johnson, on its […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Castlight Health’s second-quarter earnings report should do a good bit to allay concerns that much of its sales revenue comes from Walmart. A little more than four months since its IPO, it has deepened its Fortune 500 customer base with the likes of Texas Instruments, Kellogg, Google and Sprint Corp. It’s also expanding price transparency […]
Updated: When I tuned into Apple’s quarterly earning conference call yesterday, my goal was to get more information on its IBM collaboration, particularly what it could do with Watson’s big data capabilities in healthcare. Analysts tried but Apple wouldn’t go into details. But I did find an interesting tidbit about 13 minutes into the call […]
On a recent tour of the latest addition to University City Science Center’s campus in Philadelphia — an innovation hub in an established building on its campus set to officially open next week — I unexpectedly came across an office belonging to Merck. It’s all the more interesting because it’s just a few doors down […]
A couple weeks back I wrote about the thinking behind Medtronic’s decision to acquire Covidien and move its corporate offices to Ireland as part of a strategy to reduce its tax overhead. Like any money-saving trend, other healthcare and life sciences industry companies are following suit. Abbvie has made a play for Shire, albeit an […]
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.
An estimated 5.2 million people have post traumatic stress disorder. About 103,000 veterans of Afghanistan and Iraq have been diagnosed with the disorder, according to the Centers for Disease Control, with lots more cases expected. But there are few options available to treat the condition, aside from anti-depressants and off-label approaches. In an interview, specialty […]
Update below Drug developer Zafgen priced its IPO at the upper end of its projected share price range ($16) on the evening before its public debut on the Nasdaq. It reflects confidence in the company’s unconventional injectible drug to treat severe obesity. It’s seeking to raise $96 million to push its drug alternative to costly […]
It was always going to be hard for Castlight Health to sustain the $41-per-share price that marked its public debut in April. Since then, its share price has slipped back into the high teens. But it has overhauled the structure of its platform and added solutions to supplement its price transparency tools to help employers […]
Aside from the tax benefits, I was interested in finding out what some of the other driving forces were behind Medtronic’s $42.9 billion deal to acquire Covidien. A phone chat with Charles Whelan, Director of Consulting for Healthcare and Life Sciences for North America at Frost & Sullivan, highlighted some of the underlying trends in […]
Corporate inversion is front page news as Medtronic (NYSE: MDT) acquires Covidien (NYSE: COV) for $42.9 billion and establishes corporate offices in Ireland. It follows a similar path of tech giants Google and Microsoft, which have set up subsidiaries in Ireland. Although it plans to keep its production facilities in Minnesota, Medtronic wants to benefit […]